Cargando…

Urinary NGAL, IGFBP-7, and TIMP-2: novel biomarkers to predict contrast medium-induced acute kidney injury in children

BACKGROUND: Serum creatinine (SCr) is unreliable in detecting acute changes in kidney function. Early recognition of contrast-induced acute kidney injury (CI-AKI) can provide better opportunities for preventive interventions. Therefore, the purpose of this study is to examine the value of the combin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Qianliang, Kang, Zhijuan, Li, Zhihui, Xun, Mai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518296/ https://www.ncbi.nlm.nih.gov/pubmed/36120960 http://dx.doi.org/10.1080/0886022X.2022.2075277

Ejemplares similares

The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck(®) parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment
por: Knafl, Daniela, et al.
Publicado: (2017)

Urinary Biomarkers TIMP-2 and IGFBP7 Early Predict Acute Kidney Injury after Major Surgery
por: Gocze, Ivan, et al.
Publicado: (2015)

Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery
por: Wang, Yimei, et al.
Publicado: (2017)

Urinary TIMP-2 and IGFBP7 as Early Biomarkers of Acute Kidney Injury and Renal Recovery following Cardiac Surgery
por: Meersch, Melanie, et al.
Publicado: (2014)

Urinary TIMP2 and IGFBP7 as early biomarkers of acute kidney injury in septic and nonseptic critically ill patients
por: Cuartero , M, et al.
Publicado: (2015)

Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients
por: Daubin, Delphine, et al.
Publicado: (2017)

TIMP-2 and IGFBP7 in human kidney biopsies in renal disease
por: Schanz, Moritz, et al.
Publicado: (2023)

Urinary [TIMP-2] × [IGFBP-7] for predicting acute kidney injury in patients undergoing orthotopic liver transplantation
por: Schiefer, Judith, et al.
Publicado: (2019)

Urinary NGAL Ratio Is Not a Sensitive Biomarker for Monitoring Acute Tubular Injury in Kidney Transplant Patients: NGAL and ATI in Renal Transplant Patients
por: Kaufeld, Jessica K., et al.
Publicado: (2012)

Urinary TIMP2⋅IGFBP7 for the prediction of platinum-induced acute renal injury
por: Schanz, Moritz, et al.
Publicado: (2017)

The diagnostic accuracy of urinary [TIMP-2]·[IGFBP7] for acute kidney injury in adults: A PRISMA-compliant meta-analysis
por: Liu, Chao, et al.
Publicado: (2017)

Demographic data for urinary Acute Kidney Injury (AKI) marker [IGFBP7]·[TIMP2] reference range determinations
por: Chindarkar, Nandkishor S., et al.
Publicado: (2015)

Urinary [TIMP-2]*[IGFBP7] for early prediction of acute kidney injury after coronary artery bypass surgery
por: Pilarczyk, Kevin, et al.
Publicado: (2015)

Routine Adoption of TIMP2 and IGFBP7 Biomarkers in Cardiac Surgery for Early Identification of Acute Kidney Injury
por: Levante, Chiara, et al.
Publicado: (2018)

Potential of Urine Biomarkers CHI3L1, NGAL, TIMP-2, IGFBP7, and Combinations as Complementary Diagnostic Tools for Acute Kidney Injury after Pediatric Cardiac Surgery: A Prospective Cohort Study
por: Vandenberghe, Wim, et al.
Publicado: (2023)

Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery?
por: Wetz, Anna J, et al.
Publicado: (2015)

TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients
por: Gunnerson, Kyle J., et al.
Publicado: (2016)

Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study
por: Liu, Kathleen D., et al.
Publicado: (2016)

Urinary TIMP-2 and IGFBP7 elevate early in critically ill postoperative patients that develop AKI
por: Honore, P, et al.
Publicado: (2015)

Incidence of Acute Kidney Injury in Polytrauma Patients and Predictive Performance of TIMP2 × IGFBP7 Biomarkers for Early Identification of Acute Kidney Injury
por: Golino, Gianlorenzo, et al.
Publicado: (2022)

TIMP-2/IGFBP7 predicts acute kidney injury in out-of-hospital cardiac arrest survivors
por: Adler, Christoph, et al.
Publicado: (2018)

Evaluating TIMP-2 and IGFBP-7 as a predictive tool for kidney injury in ureteropelvic junction obstruction
por: Mello, Marcos Figueiredo, et al.
Publicado: (2021)

Association between urinary TIMP-2 and IGFBP7 as early biomarkers of AKI and oliguria during liver surgery: a prospective pilot study
por: Desmet, F, et al.
Publicado: (2015)

Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients
por: Woziwodzka, Karolina, et al.
Publicado: (2021)

Diagnostic prediction of urinary [TIMP-2] x [IGFBP7] for acute kidney injury: A meta-analysis exploring detection time and cutoff levels
por: Song, Zhenzhu, et al.
Publicado: (2017)

Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7
por: Yang, Hyun Suk, et al.
Publicado: (2022)

Kinetics of the Cell Cycle Arrest Biomarkers (TIMP2 and IGFBP7) for the Diagnosis of Acute Kidney Injury in Critically Ill COVID-19 Patients
por: Greco, Massimiliano, et al.
Publicado: (2023)

Prognostic significance of urinary NGAL in chronic kidney disease
por: Patel, Munna Lal, et al.
Publicado: (2015)

Urine TIMP2 × IGFBP7 increases 24 hours before severe AKI
por: Ostermann, M, et al.
Publicado: (2014)

The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery
por: Esmeijer, Kevin, et al.
Publicado: (2021)

The predictive value of the product of contrast medium volume and urinary albumin/creatinine ratio in contrast-induced acute kidney injury
por: Wang, Chunrui, et al.
Publicado: (2017)

Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel
por: Guzzi, Louis M., et al.
Publicado: (2019)

Urine NGAL as an early biomarker for diabetic kidney disease: accumulated evidence from observational studies
por: Tang, Xing-Yao, et al.
Publicado: (2019)

Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury
por: Westhoff, Jens H., et al.
Publicado: (2015)

Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases
por: Seibert, Felix S., et al.
Publicado: (2021)

The predictive value of [TIMP-2]*[IGFBP7] in adverse outcomes for acute kidney injury: a systematic review and meta-analysis
por: Wang, Wenlei, et al.
Publicado: (2023)

(TIMP2) x (IGFBP7) as early renal biomarker for the prediction of acute kidney injury in aortic surgery (TIGER). A single center observational study
por: Waskowski, Jan, et al.
Publicado: (2021)

Association of significantly elevated plasma levels of NGAL and IGFBP4 in patients with diabetic nephropathy
por: Ali, Hamad, et al.
Publicado: (2022)

Comparison of urinary TIMP-2 and IGFBP7 cut-offs to predict acute kidney injury in critically ill patients: A PRISMA-compliant systematic review and meta-analysis
por: Zhang, Dongquan, et al.
Publicado: (2019)

Day-to-day variation of the kidney proximal tubular injury markers urinary cystatin C, KIM1, and NGAL in patients with chronic kidney disease
por: Soveri, Inga, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t5r1v0prkridrl1uak1jv0b9gn